LATEST
2026-06-02T22:25:18+00002026-05-21T02:12:41+00002026-05-19T01:10:19+0000

Blog Small Slider

Home
Blog Small Slider

All Posts

Medical Marijuana Reclassified, But CBD Rules Largely Unchanged 0
- CANNABIS OIL
- May 5, 2026
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE
Alabama Medical Marijuana Launch Delayed Five Years, Now Set for Early May 0
- MEDICAL MARIJUANA
- April 30, 2026
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE
DOJ Reclassifies Medical Marijuana in ‘Historic’ Policy Shift 0
- MEDICAL MARIJUANA
- April 28, 2026
The U.S. Department of Justice has ordered looser federal regulation of state-legal medical marijuana, in what advocates are calling a “historic” shift in federal drug policy. Under an order signed by acting Attorney General Todd Blanche, many cannabis products will move from Schedule I, the government’s strictest drug category, to Schedule III, aligning them with
READ MORE

CBD and Hemp Seed Oil Linked to Better Jaw Function in MPD Patients 0
- CANNABIS OIL
- April 22, 2026
A new clinical trial has found that both cannabidiol (CBD) oil and hemp seed oil were associated with improved jaw function over time in patients with myofascial pain disorder (MPD) of the temporomandibular region. The randomized, double-blind, placebo-controlled study enrolled 54 adults with moderate to severe jaw pain, assigning them to either oral CBD or
READ MORE
New Study Finds Medical Cannabis May Replace Opioids and Other Prescriptions 0
- MEDICAL MARIJUANA
- April 21, 2026
A new survey of more than 3,500 patients suggests medical cannabis could significantly reduce reliance on traditional prescription drugs, including opioids, sleeping aids and antidepressants. The study, conducted by German telehealth firm Bloomwell, found patients reduced their use of medications by an average of 84.5 percent after starting medical marijuana, with nearly 59 percent stopping
READ MORE
Medicare’s First Hemp Pilot Puts CBD in Seniors’ Care Plans 0
- CANNABIS OIL
- April 14, 2026
In a historic first, Medicare is rolling out a pilot program that lets select seniors receive up to 500 dollars in hemp-based CBD products each year as part of their treatment plans. Louisville-based Cornbread Hemp has signed an exclusive agreement with Alliant Purchasing, making it the sole hemp supplier to 68,000 provider locations participating in
READ MORE